What is the main business of Solinea?

The main business activity of Solinea focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 1, 2023.

Where is the headquarters located?

The headquarters is located at: Szafranowa 6, 21-003 Elizówka.

Who is on the management board?

The management board includes Mariusz Tomasz Trus (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 200,000 (approx. $54,025).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

The company reported a revenue of $71,527,989 in 2024, which is an increase of 205.1% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $10,615,068, meaning the company increased its profit by 348.9%.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $29,788,319 in 2024, representing 51% of all operating expenses.

Solineasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-06-01

Share capital

200,000.00 PLN

Activity description

Solinea is a Polish pharmaceutical company operating in the healthcare sector. It develops and supplies more than 150 products, has 20 years of experience, and works with over 1,500 partners.

Registered address

Szafranowa 6, 21-003 Elizówka, Poland

Website

solinea.pl

Phone

Social media

Electronic delivery address

AE:PL-33919-42279-BJADW-31

Financials

Revenue history (in m)

Financial insight

Estonian CIT: Equity includes non-zero Art. 28d line items – the company is taxed under the lump-sum regime on corporate income.

Filing timeliness

1 of 4 financial statements was filed late (for 2023, 1 day late). All were audited by a statutory auditor.

202513/07/2026
202411/07/2025
202316/07/2024
202211/07/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 72.25mMedianUSD 1.07mAverageUSD 22.38m

Net profit

This companyUSD 8.74mMedianUSD 37.33kAverageUSD 879.18k

Operating costs

This companyUSD 60.35mMedianUSD 926.31kAverageUSD 21.06m

Assets

This companyUSD 77.61mMedianUSD 609.81kAverageUSD 11.84m

News

2025-08-26

Fertistim ovu – Patented Caronositol FertilityⓇ Formula Recommended for Women with PCOS and Fertility Support

2024-12-02

Muconasin – Over-the-Counter Nasal Spray with N-Acetylcysteine

2024-10-15

What is Physiomanna Baby? When and How to Use Physiomanna Baby

2024-06-29

Fertistim for Women – Inositol Sachets for PCOS, Insulin Resistance, and Prolonged Attempts to Conceive

2023-07-17

Ectodose Inhalation Solution with Ectoine Over-the-Counter, New Packaging

Industry

Offer

Prescription medicines
Over-the-counter medicines
Dietary supplements
Medical devices
Cosmetics

Website technology

Website

WordPress

Analytics and marketing

Google Analytics
Google Tag Manager

Trademarks

Solinea holds 39 active trademarks registered with the Polish Patent Office. 1 application is pending. 1 mark has expired or was not registered. The first mark was filed in 2015.

Mark	Number	Classes	Status	Protected until
PROFLEXIN(word)	Z.555117	5	Protected	Apr 21, 2033
CORNESIN(word)	Z.544632	5	Protected	Jun 30, 2032
VISELTAM(word)	Z.544587	5	Protected	Jun 30, 2032
FERICIN(word)	Z.543986	5	Protected	Jun 10, 2032
ECTOGEL(word)	Z.543792	5	Protected	Jun 6, 2032

Mark	Protected until
PROFLEXIN(word)	Apr 21, 2033
CORNESIN(word)	Jun 30, 2032
VISELTAM(word)	Jun 30, 2032
FERICIN(word)	Jun 10, 2032
ECTOGEL(word)	Jun 6, 2032

Authorized Representatives

Katarzyna Grosner – Attorney-in-fact (sole)

Mariusz Tomasz Trus – President of the Management Board

Manner of representation

If the management board is a multi-member management board, the company is represented by each member of the management board independently.

Ownership

Owner	Shares	Share value	Stake
Mariusz Tomasz Trusage 52	3,998	$53,997.84	99.95%
Others	2	$27.01	0.05%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2014-02-27.

ING Bank Śląski
41 1050 1953 1000 0090 3052 1729
ING Bank Śląski
19 1050 1953 1000 0090 3052 1737
ING Bank Śląski
14 1050 1953 1000 0024 1746 4183

Debt

No entries in the National Debtors Register (KRZ).

Real estate

Type	Amount
Buildings and premises	PLN 55,177PLN 55,177

Public aid

5 public aid cases recorded, with a total value of $914,336.

Grant date	Purpose	Gross amount	Granting body
Jun 29, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$4,096$4,096	Prezes Zakładu Ubezpieczeń Społecznych
Jun 9, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$897.5K$897,482	Polski Fundusz Rozwoju S.A.
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$4,493$4,493	Prezes Zakładu Ubezpieczeń Społecznych

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Bialmedsp. z o.o.	$203,238,055.12	bialmed.pl
Phoenix Pharma Polskasp. z o.o.	$140,768,509.34	phoenixpharma.pl
LubfarmS.A.	$123,208,945.21	lubfarm.pl
Magnapharm Polandsp. z o.o.	$90,512,785.67	magnapharm.pl
Chiesi Polandsp. z o.o.	$87,762,158.97	chiesi.pl
NettleS.A.	$85,124,937.06	nettle.pl
Perrigo Polandsp. z o.o.	$76,932,724.11	perrigo.pl
SelenaS.A.	$77,384,737.57	selena.pl
Delfarmasp. z o.o.	$63,830,205.42	delfarma.pl
UPL Polskasp. z o.o.	$64,518,791.19	upl-ltd.pl